HONDU Market Analysis

News & Sentiment

15 articles · sorted by date

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Fundamentals

Updated daily after market close
P/E ratio
EPS (TTM)0.0% YoY
Profit margin0.0%FINANCIAL SERVICES
Market cap$525.0MSmall cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
0.0%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
Last earnings
Nov 14, 2025 · Estimate $0.00 · Reported $0.07
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About HCM II Acquisition Corp. Unit

Company profile

HCM II Acquisition Corp. is a strategically focused special purpose acquisition company (SPAC) aimed at merging with high-growth enterprises within the healthcare sector. Backed by a seasoned management team with substantial industry expertise, HCM II is well-equipped to identify and capitalize on promising trends and innovations in healthcare. The firm offers institutional investors a unique opportunity to access transformative healthcare investments, driving potential value creation and fostering sustainable long-term returns in an increasingly dynamic market.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
100 FIRST STAMFORD PLACE, STAMFORD, CT
Fiscal year end
December
Latest quarter
Sep 30, 2025
Market cap$525.0M
Shares outstanding$25.0M
52W high$38.00
52W low$11.71

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer